NCT06129552 Basal Instincts: Towards Better Understanding of Basal Cell Function in Chronic Rhinosinusitis With Nasal Polyps
| NCT ID | NCT06129552 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitaire Ziekenhuizen KU Leuven |
| Condition | Chronic Rhinosinusitis With Nasal Polyps |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2023-12-19 |
| Primary Completion | 2027-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2023-12-19 with a primary completion date of 2027-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
During this project, the investigators want to explore in vitro changes in basal cells and the crosstalk with residing immune cells as potential pathogenic mechanisms in CRSwNP vs healthy controls by using surgically resected patient samples.
Eligibility Criteria
Inclusion Criteria: * Patients over the age of 18 * Males and females Exclusion Criteria: * CRSwNP * AR * Smoker, or \< 1-year ex-smoker * Underlying systematic pathology (Morbus Wegener or Churg Strauss Syndrome for example)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06129552 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Rhinosinusitis With Nasal Polyps. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06129552 currently recruiting?
Yes, NCT06129552 is actively recruiting participants. Contact the research team at peter.hellings@uzleuven.be for enrollment information.
Where is the NCT06129552 trial being conducted?
This trial is being conducted at Leuven, Belgium.
Who is sponsoring the NCT06129552 clinical trial?
NCT06129552 is sponsored by Universitaire Ziekenhuizen KU Leuven. The trial plans to enroll 300 participants.